The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection

NCT01032655 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
134
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National Taiwan University Hospital